2.61Open3.74Pre Close11 Volume120 Open Interest75.00Strike Price2.83KTurnover707.52%IV0.47%PremiumDec 13, 2024Expiry Date2.19Intrinsic Value100Multiplier-1DDays to Expiry0.36Extrinsic Value100Contract SizeAmericanOptions Type0.9861Delta0.0350Gamma35.09Leverage Ratio-12.9227Theta0.0000Rho34.60Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet